Correlation Between Dupont De and AcelRx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Dupont De and AcelRx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and AcelRx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and AcelRx Pharmaceuticals, you can compare the effects of market volatilities on Dupont De and AcelRx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of AcelRx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and AcelRx Pharmaceuticals.
Diversification Opportunities for Dupont De and AcelRx Pharmaceuticals
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Dupont and AcelRx is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and AcelRx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AcelRx Pharmaceuticals and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with AcelRx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AcelRx Pharmaceuticals has no effect on the direction of Dupont De i.e., Dupont De and AcelRx Pharmaceuticals go up and down completely randomly.
Pair Corralation between Dupont De and AcelRx Pharmaceuticals
Allowing for the 90-day total investment horizon Dupont De Nemours is expected to generate 0.26 times more return on investment than AcelRx Pharmaceuticals. However, Dupont De Nemours is 3.9 times less risky than AcelRx Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. AcelRx Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest 7,098 in Dupont De Nemours on August 31, 2024 and sell it today you would earn a total of 1,261 from holding Dupont De Nemours or generate 17.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 28.45% |
| Values | Daily Returns |
Dupont De Nemours vs. AcelRx Pharmaceuticals
Performance |
| Timeline |
| Dupont De Nemours |
| AcelRx Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Dupont De and AcelRx Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dupont De and AcelRx Pharmaceuticals
The main advantage of trading using opposite Dupont De and AcelRx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, AcelRx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AcelRx Pharmaceuticals will offset losses from the drop in AcelRx Pharmaceuticals' long position.| Dupont De vs. Eastman Chemical | Dupont De vs. Linde plc Ordinary | Dupont De vs. Ecolab Inc | Dupont De vs. Sherwin Williams Co |
| AcelRx Pharmaceuticals vs. Lifecore Biomedical | AcelRx Pharmaceuticals vs. Shuttle Pharmaceuticals | AcelRx Pharmaceuticals vs. Catalent | AcelRx Pharmaceuticals vs. Tilray Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |